An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Chronic Hepatitis B
Interventions
DRUG

Entecavir

Tablet, P.O. 0.5, 1 mg, once daily

Trial Locations (48)

480-1195

Local Institution, Aichi-Gun

457-0866

Local Institution, Nagoya

466-8550

Local Institution, Nagoya

467-8602

Local Institution, Nagoya

Unknown

Local Institution, Chiba

Local Institution, Kurume

Local Institution, Takamatsu

Local Institution, Kyoto

Local Institution, Sendai

Local Institution, Nagasaki

Local Institution, Niigata

Local Institution, Osaka

Local Institution, Suita-Shi

791-0204

Local Institution, Onsen-Gun

814-0180

Local Institution, Fukuoka

500-8513

Local Institution, Gifu

503-8502

Local Institution, Ogaki-Shi

721-0971

Local Institution, Fukuyama-Shi

730-8518

Local Institution, Hiroshima

734-0037

Local Institution, Hiroshima

070-0054

Local Institution, Asahikawa-Shi

006-0813

Local Institution, Sapporo

060-0033

Local Institution, Sapporo

673-0848

Local Institution, Akashi-Shi

020-8505

Local Institution, Morioka

769-1601

Local Institution, Mitoyo-Gun

860-8556

Local Institution, Kumamoto

889-1692

Local Institution, Miyazaki-Gun

390-0802

Local Institution, Matsumoto

856-0000

Local Institution, Omura-Shi

879-5503

Local Institution, Oita-Gun

710-8602

Local Institution, Kurashiki-Shi

700-0082

Local Institution, Okayama

700-8505

Local Institution, Okayama

700-8511

Local Institution, Okayama

708-0841

Local Institution, Tsuyama-Shi

86-0008

Local Institution, Kawachinagano-Shi

553-0003

Local Institution, Osaka

591-8025

Local Institution, Sakai-Shi

350-0495

Local Institution, Iruma-Gun

105-0001

Local Institution, Minato-Ku

180-0023

Local Institution, Musashino-Shi

160-8582

Local Institution, Shinjuku-Ku

162-8655

Local Institution, Shinjuku-Ku

162-8666

Local Institution, Shinjuku-Ku

173-8610

Local Institution, Tokyo

755-0067

Local Institution, Ube-Shi

409-3821

Local Institution, Nakakoma-Gun

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01037062 - An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection | Biotech Hunter | Biotech Hunter